Brian T. Crum - 28 Feb 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, General Counsel & Secr.
Signature
/s/ Brian T. Crum
Issuer symbol
LXRX
Transactions as of
28 Feb 2022
Net transactions value
-$42,918
Form type
4
Filing time
28 Feb 2022, 18:13:52 UTC
Previous filing
14 Feb 2022
Next filing
13 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +11,100 +15% 84,737 28 Feb 2022 Direct F1
transaction LXRX Common Stock Options Exercise +21,030 +25% 105,767 28 Feb 2022 Direct F1
transaction LXRX Common Stock Options Exercise +8,750 +8.3% 114,517 28 Feb 2022 Direct F1
transaction LXRX Common Stock Tax liability $42,918 -15,059 -13% $2.85 99,458 28 Feb 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -11,100 -100% 0 28 Feb 2022 Common Stock 11,100 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -21,030 -50% 21,030 28 Feb 2022 Common Stock 21,030 Direct F1, F4
transaction LXRX Restricted Stock Units Options Exercise -8,750 -33% 17,500 28 Feb 2022 Common Stock 8,750 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter.
F4 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.